Literature DB >> 23351115

Detailed analysis of biased histamine H₄ receptor signalling by JNJ 7777120 analogues.

S Nijmeijer1, H F Vischer, F Sirci, S Schultes, H Engelhardt, C de Graaf, E M Rosethorne, S J Charlton, R Leurs.   

Abstract

BACKGROUND AND
PURPOSE: The histamine H₄ receptor, originally thought to signal merely through Gαi proteins, has recently been shown to also recruit and signal via β-arrestin2. Following the discovery that the reference antagonist indolecarboxamide JNJ 7777120 appears to be a partial agonist in β-arrestin2 recruitment, we have identified additional biased hH₄R ligands that preferentially couple to Gαi or β-arrestin2 proteins. In this study, we explored ligand and receptor regions that are important for biased hH₄R signalling. EXPERIMENTAL APPROACH: We evaluated a series of 48 indolecarboxamides with subtle structural differences for their ability to induce hH₄R-mediated Gαi protein signalling or β-arrestin2 recruitment. Subsequently, a Fingerprints for Ligands and Proteins three-dimensional quantitative structure-activity relationship analysis correlated intrinsic activity values with structural ligand requirements. Moreover, a hH₄R homology model was used to identify receptor regions important for biased hH₄R signalling. KEY
RESULTS: One indolecarboxamide (75) with a nitro substituent on position R7 of the aromatic ring displayed an equal preference for the Gαi and β-arrestin2 pathway and was classified as unbiased hH₄R ligand. The other 47 indolecarboxamides were β-arrestin2-biased agonists. Intrinsic activities of the unbiased as well as β-arrestin2-biased indolecarboxamides to induce β-arrestin2 recruitment could be correlated with different ligand features and hH₄R regions. CONCLUSION AND IMPLICATIONS: Small structural modifications resulted in diverse intrinsic activities for unbiased (75) and β-arrestin2-biased indolecarboxamides. Analysis of ligand and receptor features revealed efficacy hotspots responsible for biased-β-arrestin2 recruitment. This knowledge is useful for the design of hH₄R ligands with biased intrinsic activities and aids our understanding of the mechanism of H₄R activation.
© 2013 The Authors. British Journal of Pharmacology © 2013 The British Pharmacological Society.

Entities:  

Keywords:  FLAP 3D-QSAR; biased ligands; efficacy; efficacy hotspots; histamine H4 receptor; indolecarboxamides; intrinsic activity; β-arrestin

Mesh:

Substances:

Year:  2013        PMID: 23351115      PMCID: PMC3764851          DOI: 10.1111/bph.12117

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  58 in total

1.  Structure and expression of the human histamine H4-receptor gene.

Authors:  F Cogé; S P Guénin; H Rique; J A Boutin; J P Galizzi
Journal:  Biochem Biophys Res Commun       Date:  2001-06-08       Impact factor: 3.575

Review 2.  Molecular and biochemical pharmacology of the histamine H4 receptor.

Authors:  Rob Leurs; Paul L Chazot; Fiona C Shenton; Herman D Lim; Iwan J P de Esch
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

3.  Serine and threonine residues bend alpha-helices in the chi(1) = g(-) conformation.

Authors:  J A Ballesteros; X Deupi; M Olivella; E E Haaksma; L Pardo
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

4.  Virtual fragment screening: discovery of histamine H3 receptor ligands using ligand-based and protein-based molecular fingerprints.

Authors:  Francesco Sirci; Enade P Istyastono; Henry F Vischer; Albert J Kooistra; Saskia Nijmeijer; Martien Kuijer; Maikel Wijtmans; Raimund Mannhold; Rob Leurs; Iwan J P de Esch; Chris de Graaf
Journal:  J Chem Inf Model       Date:  2012-12-03       Impact factor: 4.956

5.  Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes.

Authors:  T Oda; N Morikawa; Y Saito; Y Masuho; S Matsumoto
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

6.  Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.

Authors:  Vsevolod Katritch; Kimberly A Reynolds; Vadim Cherezov; Michael A Hanson; Christopher B Roth; Mark Yeager; Ruben Abagyan
Journal:  J Mol Recognit       Date:  2009 Jul-Aug       Impact factor: 2.137

7.  Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor.

Authors:  Michael Zocher; Juan J Fung; Brian K Kobilka; Daniel J Müller
Journal:  Structure       Date:  2012-06-28       Impact factor: 5.006

8.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

9.  Delineation of agonist binding to the human histamine H4 receptor using mutational analysis, homology modeling, and ab initio calculations.

Authors:  Aldo Jongejan; Herman D Lim; Rogier A Smits; Iwan J P de Esch; Eric Haaksma; Rob Leurs
Journal:  J Chem Inf Model       Date:  2008-06-14       Impact factor: 4.956

10.  Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor.

Authors:  Niu Shin; Elizabeth Coates; Nicholas J Murgolo; Kelley L Morse; Marvin Bayne; Catherine D Strader; Frederick J Monsma
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

View more
  13 in total

Review 1.  Histamine H₄ receptors in the gastrointestinal tract.

Authors:  A Deiteren; J G De Man; P A Pelckmans; B Y De Winter
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 2.  Structural Analysis of Chemokine Receptor-Ligand Interactions.

Authors:  Marta Arimont; Shan-Liang Sun; Rob Leurs; Martine Smit; Iwan J P de Esch; Chris de Graaf
Journal:  J Med Chem       Date:  2017-03-10       Impact factor: 7.446

3.  Histamine H3 and H4 receptor ligands modify vascular histamine levels in normal and arthritic large blood vessels in vivo.

Authors:  Konstantinos Kyriakidis; Evangelia Zampeli; Marina Palaiologou; Dina Tiniakos; Ekaterini Tiligada
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 4.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 5.  Pharmacological Characterization of Human Histamine Receptors and Histamine Receptor Mutants in the Sf9 Cell Expression System.

Authors:  Erich H Schneider; Roland Seifert
Journal:  Handb Exp Pharmacol       Date:  2017

Review 6.  The receptor concept in 3D: from hypothesis and metaphor to GPCR-ligand structures.

Authors:  Albert J Kooistra; Chris de Graaf; Henk Timmerman
Journal:  Neurochem Res       Date:  2014-08-08       Impact factor: 3.996

Review 7.  Histamine pharmacology: from Sir Henry Dale to the 21st century.

Authors:  Ekaterini Tiligada; Madeleine Ennis
Journal:  Br J Pharmacol       Date:  2018-12-02       Impact factor: 8.739

8.  Histamine pharmacology: four years on.

Authors:  Paul L Chazot
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 9.  The expanding role of immunopharmacology: IUPHAR Review 16.

Authors:  Ekaterini Tiligada; Masaru Ishii; Carlo Riccardi; Michael Spedding; Hans-Uwe Simon; Mauro Martins Teixeira; Mario Landys Chovel Cuervo; Stephen T Holgate; Francesca Levi-Schaffer
Journal:  Br J Pharmacol       Date:  2015-07-21       Impact factor: 8.739

Review 10.  Biased G Protein-Coupled Receptor Signaling: New Player in Modulating Physiology and Pathology.

Authors:  Zuzana Bologna; Jian-Peng Teoh; Ahmed S Bayoumi; Yaoliang Tang; Il-Man Kim
Journal:  Biomol Ther (Seoul)       Date:  2017-01-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.